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Abstract
Background: The human chromosomal region 9p21.3 has been shown to be strongly associated with Coronary
Heart Disease (CHD) in several Genome-wide Association Studies (GWAS). Recently, this region has also been
shown to be associated with Aggressive Periodontitis (AgP), strengthening the hypothesis that the established
epidemiological association between periodontitis and CHD is caused by a shared genetic background, in addition
to common environmental and behavioural risk factors. However, the size of the analyzed cohorts in this primary
analysis was small compared to other association studies on complex diseases. Using our own AgP cohort, we
attempted to confirm the described associations for the chromosomal region 9p21.3.
Methods: We analyzed our cohort consisting of patients suffering from the most severe form of AgP, generalized
AgP (gAgP) (n = 130) and appropriate periodontally healthy control individuals (n = 339) by genotyping four
tagging SNPs (rs2891168, rs1333042, rs1333048 and rs496892), located in the chromosomal region 9p21.3, that have
been associated with AgP.
Results: The results confirmed significant associations between three of the four SNPs and gAgP. The combination
of our results with those from the study which described this association for the first time in a meta-analysis of the
four tagging SNPs produced clearly lower p-values compared with the results of each individual study. According
to these results, the most plausible genetic model for the association of all four tested SNPs with gAgP seems to
be the multiplicative one.
Conclusion: We positively replicated the finding of an association between the chromosomal region 9p21.3 and
gAgP. This result strengthens support for the hypothesis that shared susceptibility genes within this chromosomal
locus might be involved in the pathogenesis of both CHD and gAgP.
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Background
Periodontitis is a complex inflammatory disease charac-
terized by progressive destruction of the surrounding
connective tissue and supporting alveolar bone of the
teeth [1]. In adults older than 40 years, it represents the
major cause of tooth loss [2]. For the most severe form
of periodontitis, aggressive periodontitis (AgP), the pre-
valence has been reported to range between 0.1 and
15% among Caucasians, Hispanics and African Ameri-
cans [3]. In European Caucasians, the prevalence for
AgP has been estimated to be between 0.1 and 1% of
the general population [4]. Family studies have indicated
an increased prevalence of AgP among siblings with 40-
50% being affected. However, the exact mode of inheri-
tance of AgP remains unclear [3].
Coronary heart disease (CHD) is a complex systemic
disorder representing the leading cause of death world-
wide [5]. As for AgP, it has been known for a long time
that CHD is strongly influenced by genetic factors [6],
but it was not until recently that genetic risk loci contri-
buting to the development of the disease were identified.
An association between CHD and periodontitis has been
clearly established [7,8]. Both diseases have several
environmental and behavioural risk factors in common
such as education, smoking, and diabetes mellitus [8,9].
It is assumed that, in addition to common environmen-
tal and behavioural risk factors, this association might
also be based on a shared genetic background. Imbal-
ances in immune responses and dysregulation of chronic
inflammation are typical attributes of both CHD and
periodontitis [10,11]. These similarities point towards
the possibility that both diseases have common underly-
ing pathogenic mechanisms, modulated by shared
genetic susceptibility loci.
In 2007, four independent GWAS which identified
susceptibility loci for CHD were published [12-15]. All
studies reported a strong association of a region of ele-
vated linkage disequilibrium (LD) on human chromo-
some 9p21.3 with CHD. The identified region is located
upstream of the CDKN2A and CDKN2B genes. A subse-
quent meta-analysis confirmed this association [16] and
the described locus on 9p21.3 now represents the best
replicated genetic CHD risk locus.
Recently, Schaefer et al. (2009) [17] investigated the
hypothesis that shared susceptibility loci might increase
the risk for periodontitis as well as CHD. They analyzed
the 9p21.3 locus for a possible association with AgP in
which genetic factors play an important role [18]. Given
the postulated higher penetrance of susceptibility genes in
AgP compared to chronic periodontitis, this approach was
assumed to increase the likelihood to detect statistically
significant associations. Schaefer and co-workers [17] gen-
otyped six tagging SNPs located within the 9p21.3 locus
which they subdivided into two defined regions with three
tagging SNPs in each. This approach allowed the mapping
of the corresponding LD regions (rs2891168, rs1333042,
rs1333048 for LD region 1; rs7044859, rs7865618,
rs496892 for LD region 2). Genotyping results generated
using DNA samples from patients suffering either from
localized or generalized AgP were compared to data
obtained using DNA samples from control individuals
without AgP. Schaefer et al. (2009) [17] were able to
demonstrate statistically significant associations of all tag-
ging SNPs of LD region 1 and of rs496892 from LD region
2 with localized AgP and even stronger associations with
gAgP. The SNPs rs7044859 and rs7865618 did not show
any association. The study confirmed the prediction that
shared susceptibility genes might be involved in the devel-
opment of CHD and AgP. However, due to the limited
size of the cohorts analyzed (159 generalized AgP patients
versus 736 healthy controls and 146 localized AgP patients
versus 368 healthy controls) that were small compared to
other association studies on complex diseases, the authors
emphasized the need for confirmation of the described
association in further and/or larger AgP populations.
In the present study, we analyzed a cohort of 130 AgP
patients and 339 appropriate periodontally healthy con-
trol individuals and genotyped the four tagging SNPs
(rs2891168, rs1333042, rs1333048 and rs496892) that
had been associated with AgP by Schaefer et al. (2009)
[17]. Our AgP patient cohort comprised exclusively indi-
viduals with gAgP. Patients suffering from this most
severe form of AgP showed the strongest association
findings in the study of Schaefer and co-workers [17],
and therefore, our cohort, exhibiting a similar size as
the gAgP cohort in their study, should be adequately
suited to confirm their results.
Methods
Study Population
The study was limited to Caucasians with a minimum of
20 teeth. In order to ensure a common Caucasian back-
ground, only subjects of German or Northern Irish eth-
nicity were included. The 130 gAgP cases were recruited
by outpatient departments throughout Germany (n =
85) and Northern Ireland (n = 45). The gAgP cohort
consisted of 53 males (41%) and 77 females (59%). The
age at the time of the first diagnosis of gAgP ranged
between 15 and 35 years, (inclusion criterion: age ≤ 35
years), the mean age at the time of diagnosis was 30.1
years, the median age 32 years. To be classified with
gAgP where full-mouth dental radiographs were avail-
able, at least one third of all teeth had to exhibit at least
50% bone loss. In cases where no radiographs were
available, a minimum of one third of all teeth had to
have clinical attachment loss of ≥ 5 mm.
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The 339 control subjects without AgP were also
recruited from Germany (n = 225) and Northern Ireland
(n = 114). The majority of the German controls (n = 172)
were selected from the epidemiological Study of Health
in Pomerania (SHIP) [19]. All SHIP participants received
an extensive dental examination including assessment of
tooth count and location, of probing depth and clinical
attachment loss [20]. Information on various risk factors
including smoking status, school education and diabetes
were obtained through interviews as a part of the medical
examination. The remaining German control individuals
(n = 53) were recruited by periodontal departments
throughout Germany. All Northern Irish controls were
participants in the Prospective Epidemiological Study of
Myocardial Infarction [21] who had a periodontal exami-
nation [22]. The control cohort consisted of 196 males
(58%) and 143 females (42%). The age of the control indi-
viduals at the time of the dental examination ranged
between 40 and 80 years, (exclusion criterion: age < 40
years), the mean age at the time of examination was 55
years, the median age 56.2 years. All controls had to have
a minimum of 20 teeth and no clinical attachment loss of
≥ 5 mm. All cases and controls gave their written
informed consent for the study. The study was approved
by the local institutional review board (Ethics Commis-
sion of the Ernst Moritz Arndt University Greifswald,
Medical Faculty, registration number BB 05/07). In the
current work, the described study population is subse-
quently referred to as the “Greifswald cohort”.
Genotyping
Genomic DNA was extracted from blood samples using
the QIAamp DNA blood mini kit (Qiagen, Hilden,
Germany) following the manufacturer’s instruction. Pur-
ity and concentration of the DNA was determined using
a NanoDrop® ND-1000 UV-Vis Spectrophotometer
(NanoDrop Technologies, Wilmington, USA), and the
integrity of each DNA preparation was verified by gel
electrophoresis on 0.8% Agarose-1 × TBE gels stained
with ethidium bromide.
Genotyping was performed using an Applied Biosystems
7900HT Fast Real-Time PCR System and the TaqMan
Genotyping System (Applied Biosystems, Foster City, CA,
USA). All TaqMan assays used in this study were pur-
chased from Applied Biosystems (Darmstadt, Germany)
and performed according to the manufacturer’s instruc-
tions. Genotypes were generated by automatic calling
using the SDS 2.3 software (Applied Biosystems). All gen-
otypes were furthermore reviewed manually.
Statistical Analysis
Unadjusted and adjusted case-control analysis was per-
formed using PLINK v1.06 [23]. We assessed the signifi-
cance of associations between genotypes and gAgP using
logistic regression. The adjusted model was computed by
multiple logistic regression analysis adjusting for indivi-
dual’s gender and smoking status. Each individual was
classified as never, former or current smoker based on
self-reported or interview based information. The smok-
ing status was addressed in the regression model by
implementing two dummy variables indicating former
and current smoking, with never smokers as the refer-
ence. Finally, three covariates were added for adjustment:
one for gender and two coding the smoking status.
Meta-analysis was performed in R v2.8.0 http://www.r-
project.org using a sample size weighted fixed effect
model. To perform the appropriate analyses, we
matched the effect alleles of the Greifswald cohort to
the effect allele of Schaefer and co-workers (2009) [17].
Additional software and tools used for analyses included
Haploview [24], UCSC genome browser http://genome.
ucsc.edu, HapMap http://www.hapmap.org and Medline.
Results
Minor allele frequencies of the analyzed SNPs rs2891168,
rs1333042, rs1333048, and rs496892
Allele frequencies for the minor alleles of all four SNPs
genotyped in this study were around 50% (see Table 1).
For SNPs rs2891168, rs1333042, and rs1333048 the
minor alleles (G, G, and C, respectively) were the same
as described by Schaefer and co-workers (2009) [17].
The effect allele of rs496892 was around 50% in our
study as well as in the study of Schaefer and co-workers
(2009) (A to G) [1]. All four analyzed SNPs were found
to be in Hardy-Weinberg-Equilibrium (HWE) in our
cohort (pHWE > 0.01) (Table 2).
Analysis for Association with gAgP using unadjusted
SNP data
Dominant, recessive, and multiplicative models were
used to test for associations with gAgP in both unad-
justed and adjusted SNP data. The results for the unad-
justed analyses are summarized in Table 3. Without
adjustment, rs2891168 was significantly associated with
gAgP in a dominant and a multiplicative model,
Table 1 Allele frequencies in study populations of
interest
CHR SNP ID Greifswald cohort Schaefer et al. cohort
A1 A2 FA1 FA2 A1 A2 FA1 FA2
9 rs2891168 G A 0.47 0.53 G A 0.46 0.54
9 rs1333042 G A 0.49 0.51 G A 0.48 0.52
9 rs1333048 C A 0.49 0.51 C A 0.47 0.53
9 rs496892 A G 0.49 0.51 G A 0.49 0.51
CHR: Chromosome; A1: Minor allele; A2: Major allele; FA1: Allele frequency of
the minor allele in the respective cohort; FA2: Allele frequency of the major
allele in the respective cohort.
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respectively, [p = 2.89 × 10-02, OR = 1.71 (1.06-2.77) and
p = 4.92 × 10-02, OR = 1.33 (1.00-1.77)], demonstrating
stronger association in the dominant model. In contrast,
in the case of rs1333042, none of the three genetic mod-
els produced values below the significance threshold. The
two SNPs rs1333048 and rs496892 were both signifi-
cantly associated with gAgP in a multiplicative model
[p = 3.95 × 10-02, OR = 1.35 (1.02-1.80) and p = 1.38 ×
10-02, OR = 1.47 (1.09-2.00), respectively], but only
rs496892 did also show significant association in the
dominant model [p = 2.03 × 10-02, OR = 1.71 (1.09-
2.70)]. Using a recessive model, none of the four SNPs
showed a significant association with gAgP.
Analysis for Association with gAgP using adjusted SNP
data
In the next step, analyses were adjusted for the covari-
ates gender and smoking. Using the multiplicative
model, the SNPs rs1333048 and rs496892 exhibited a
statistically significant association with gAgP, whereas in
the dominant model, only rs2891168 and rs496892
demonstrated significant associations. Again, as was the
case with the unadjusted data, rs1333042 did not show
significant association with gAgP in any of the three
models. Furthermore, in the recessive model, none of
the four SNPs was significantly associated with gAgP
(Table 3).
Taken together, two of the SNPs of the LD region 1,
(rs2891168 and rs1333048) demonstrated significant
association with gAgP in the multiplicative model,
whereas only rs2891168 was also significantly associated
in the dominant model. The association of rs2891168
with gAgP was stronger in the dominant than the multi-
plicative model, using both unadjusted data [p = 2.89 ×
10-02, OR = 1.71 (1.06-2.77) versus p = 4.92 × 10-02, OR
= 1.33 (1.00-1.77)] and adjusted data [p = 4.73 × 10-02,
OR = 1.70 (1.01-2.88) versus p = 6.44 × 10-02, OR =
1.35 (0.98-1.85)]. In the case of rs1333048, using unad-
justed as well as adjusted data, the multiplicative model
produced similar significant associations [p = 1.38 × 10-
02, OR = 1.47 (1.09-2.00) and p = 4.22 × 10-02, OR =
1.39 (1.01-1.91)]. The SNP rs496892 that represented
LD region 2 was significantly associated with gAgP in
Table 2 Hardy-Weinberg-Equilibrium of all SNPs analyzed
in the Greifswald cohort
CHR SNP ID HWE
TEST
A1 A2 GENO O
(HET)
E
(HET)
HW p-
value
9 rs2891168 ALL G A 108/229/
132
0.49 0.50 0.64
9 rs2891168 AFF G A 34/69/27 0.53 0.50 0.60
9 rs2891168 UNAFF G A 74/160/
105
0.47 0.50 0.38
9 rs1333042 ALL G A 111/231/
125
0.49 0.50 0.85
9 rs1333042 AFF G A 35/68/27 0.52 0.50 0.72
9 rs1333042 UNAFF G A 76/163/
98
0.48 0.50 0.59
9 rs1333048 ALL C A 114/229/
126
0.49 0.50 0.64
9 rs1333048 AFF C A 38/65/27 0.50 0.50 1.00
9 rs1333048 UNAFF C A 76/164/
99
0.48 0.50 0.66
9 rs496892 ALL T C 99/257/
113
0.55 0.50 0.04
9 rs496892 AFF T C 21/68/41 0.52 0.49 0.48
9 rs496892 UNAFF T C 78/189/
72
0.56 0.50 0.04
CHR: Chromosome; HWE Test: Test of the respective SNP for Hardy-Weinberg
Equilibrium for all analyzed individuals (ALL), cases with gAgP (AFF), and
control subjects unaffected by gAgP (UNAFF); A1: Minor allele; A2: Major allele;
GENO: Genotype counts: Number of individuals homozygous for the minor
allele/Number of heterozygous individuals/Number of individuals homozygous
for the major allele; O(HET): Observed heterozygosity; E(HET): Expected
heterozygosity; HW p-value: Hardy-Weinberg p-value.
Table 3 Associations of the four candidate SNPs with generalized Aggressive Periodontitis (gAgP) in the Greifswald
cohort
Recessive model Multiplicative model Dominant model
SNP ID P OR 95% CI P OR 95% CI P OR 95% CI
Unadjusted analysis rs2891168 3.20 × 10-01 1.27 0.79-2.03 4.92 × 10-02 1.33 1.00-1.77 2.89 × 10-02 1.71 1.06-2.77
rs1333042 3.21 × 10-01 1.27 0.80-2.01 8.46 × 10-02 1.29 0.97-1.71 7.04 × 10-02 1.56 0.96-2.54
rs1333048 1.25 × 10-01 1.43 0.91-2.26 3.95 × 10-02 1.35 1.02-1.80 6.64 × 10-02 1.57 0.97-2.55
rs496892 1.05 × 10-01 1.55 0.90-2.63 1.38 × 10-02 1.47 1.09-2.00 2.03 × 10-02 1.71 1.09-2.70
Adjusted analysis rs2891168 3.18 × 10-01 1.303 0.77-2.19 6.44 × 10-02 1.35 0.98-1.85 4.73 × 10-02 1.70 1.01-2.88
rs1333042 2.88 × 10-01 1.321 0.79-2.21 9.51 × 10-02 1.31 0.95-1.80 9.99 × 10-02 1.56 0.92-2.64
rs1333048 1.18 × 10-01 1.498 0.90-2.49 4.22 × 10-02 1.39 1.01-1.91 7.95 × 10-02 1.60 0.95-2.72
rs496892 2.20 × 10-01 1.43 0.81-2.55 4.51 × 10-02 1.41 1.01-1.98 4.94 × 10-02 1.65 1.00-2.72
Association statistics are shown for cases consisting of individuals affected with gAgP and controls consisting of individuals unaffected by gAgP. OR: Odds Ratio;
95% CI: 95% Confidence Intervals; P: p-values obtained by logistic regression using PLINK v1.06 [23]. Values are given before and after adjustment for the
covariates smoking and gender. The parameters for the genetic models producing the strongest significant associations are given in boldface for each SNP for
adjusted as well as unadjusted analyses.
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the multiplicative and in the dominant model using
unadjusted as well as adjusted data, with the association
stronger in both cases when the multiplicative model
was used (Table 3).
Meta-Analysis for Association with gAgP using all
available data for the SNPs rs2891168, rs1333042,
rs1333048, and rs496892
To maximize the statistical power of the association
analyses, we finally performed a meta-analysis for the
SNPs rs2891168, rs1333042, rs1333048, and rs496892
combining our adjusted data with those from Schaefer
and co-workers (2009) [17] for multiplicative, recessive,
and dominant models. In the multiplicative model, all
four tested SNPs were significantly associated with
gAgP, even after Bonferroni correction (see Table 4). In
this model, rs1333048 exhibited the strongest associa-
tion with p = 1.09 × 10-03. For all four SNPs, the meta-
analysis produced lower p-values in the multiplicative
model compared to the results obtained using the geno-
typing data from the two single cohorts. Using a reces-
sive model in the meta-analysis, only the SNPs
representing LD region 1 (rs2891168, rs1333042,
rs1333048) were significantly associated with gAgP,
whereas rs496892 representing LD region 2 did not fall
below the threshold of significance. As in the case of
the multiplicative model, rs1333048 showed the stron-
gest association with gAgP with p = 9.97 × 10-04. How-
ever, whereas in the multiplicative model the p-values
produced in the meta-analysis were lower than those
obtained with the two single cohorts, this was not the
case in the recessive one: here, the p-values from the
meta-analysis, while being predominantly lower com-
pared to those obtained solely with the Greifswald
cohort, were higher than the values obtained when only
the Schaefer et al. cohort was used. Using a dominant
model in the meta-analysis, only rs496892 representing
LD region 2 exhibited significant association after Bon-
ferroni correction with p = 1.24 × 10-02, with this value
being lower than those obtained using the two single
cohorts (p = 4.94 × 10-02 and p = 2.60 × 10-02 for the
Greifswald and the Schaefer et al. cohort [17],
respectively).
In summary, the lowest p-values in total were
obtained for rs2891168, rs1333042, and rs496892 when
the multiplicative model was used, and in the case of
rs1333048, the value was only marginally lower in the
recessive (p = 9.97 × 10-04) as compared to the multipli-
cative model (p = 1.09 × 10-03). Therefore, the multipli-
cative model generated the most consistent results and
appeared to be the most plausible model for the associa-
tion of all four tested SNPs with gAgP.
Discussion
The main finding of the current study was the replica-
tion of statistically significant associations between three
defined SNPs located on human chromosome 9p21.3
and gAgP. The locus on chromosome 9p21.3, which had
Table 4 Meta-Analysis for Association of the four candidate SNPs with generalized Aggressive Periodontitis (gAgP)
using the adjusted data from the Greifswald cohort and those published by Schaefer and co-workers [17]
SNP ID P
Greifswald
cohort
n
Greifswald
cohort
P
Schaefer et al.
cohort
n
Schaefer et al.
cohort
P
Meta-
Analysis
P (BON)
Meta-
Analysis
Recessive model rs2891168 3.18 × 10-01 468 8.80 × 10-04 879 1.06 × 10-03 4.22 × 10-03
rs1333042 2.88 × 10-01 466 1.60 × 10-03 879 1.49 × 10-03 5.95 × 10-03
rs1333048 1.18 × 10-01 468 6.90 × 10-04 876 2.49 × 10-04 9.97 × 10-04
rs496892 2.20 × 10-01 468 1.50 × 10-01 862 5.92 × 10-02 2.37 × 10-01
Multiplicative
model
rs2891168 6.44 × 10-02 468 4.40 × 10-03 879 6.97 × 10-04 2.79 × 10-03
rs1333042 9.51 × 10-02 466 4.80 × 10-03 879 1.10 × 10-03 4.42 × 10-03
rs1333048 4.22 × 10-02 468 2.50 × 10-03 876 2.73 × 10-04 1.09 × 10-03
rs496892 4.51 × 10-02 468 2.40 × 10-02 862 2.65 × 10-03 1.06 × 10-02
Dominant
model
rs2891168 4.73 × 10-02 468 1.40 × 10-01 879 1.82 × 10-02 7.28 × 10-02
rs1333042 9.99 × 10-02 466 1.20 × 10-01 879 2.60 × 10-02 1.04 × 10-01
rs1333048 7.95 × 10-02 468 9.60 × 10-02 876 1.74 × 10-02 6.95 × 10-02
rs496892 4.94 × 10-02 468 2.60 × 10-02 862 3.10 × 10-03 1.24 × 10-02
Association statistics are shown for the Greifswald total cohort consisting of cases affected with gAgP and control subjects unaffected by gAgP and for the gAgP
cases and the corresponding controls described in Schaefer et al. (2009) [17]. P: p-values obtained by logistic regression using PLINK; n: Number of individuals in
the corresponding cohorts; P Meta-Analysis and P (BON) Meta-Analysis: p-values of the Meta-Analyses using z statistics before and after Bonferroni correction.
Values are given after adjustment for the covariates smoking and gender. The parameters for the genetic models producing the strongest significant associations
are given in boldface for each SNP before and after Bonferroni correction.
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previously been shown to be associated with CHD, was
recently associated with gAgP (Figure 1) [17]. The repli-
cation analysis in our independent cohort, consisting of
130 gAgP patients and 339 periodontally healthy control
subjects without gAgP, strengthened the findings of
Schaefer et al. (2009) [17]. This result corroborates the
idea that the chromosomal locus on 9p21.3 may repre-
sent one of the postulated genetic links between CHD
and periodontitis. Furthermore, combining the results of
Schaefer et al. and our own results in a meta-analysis
resulted in an improved statistical power due to the
increase in the total number of analyzed individuals.
The results of this meta-analysis favour a multiplicative
model of inheritance for the genetic variant that is asso-
ciated with gAgP.
Detailed functional analyses of the 9p21.3 region have
been completed (Figure 2) to determine the molecular
mechanisms underlying the increased risk for CHD
[25,26]. Within this locus, the non-coding ANRIL RNA
overlaps with the upstream promoter region of the
genes CDKN2A and ARF, whereby ARF shares two
exons with CDKN2A, and the complete sequence of the
CDKN2B gene. While CDKN2A, ARF, and CDKN2B are
transcribed in the same direction, ANRIL is transcribed
in the opposite direction (Figure 2). Both CDKN2A and
CDKN2B encode cyclin-dependent kinase inhibitors,
namely p16INK4a and p15INK4b. The gene product of
ARF is able to bind and sequester MDM1, a protein
responsible for the degradation of p53, and so acts as a
stabilizer of the tumor suppressor protein p53. There-
fore, these three genes specify proteins involved in cell
cycle inhibition.
Liu et al. (2009) [26] analyzed the expression of sev-
eral transcripts specified by the 9p21.3 region in purified
peripheral blood T-cells (PBTL) from 170 healthy
donors. These samples were genotyped for six selected
disease-related SNPs spanning the locus. The PBTL of
individuals that harbored a common SNP (rs10757278)
had significantly reduced expression of all transcripts
encoded by the 9p21.3 region, namely CDKN2A,
CDKN2B, ARF and ANRIL. The SNP (rs10757278) has
been associated with an increased risk of CHD, stroke
and aortic aneurysm and is located downstream of the
3′-end of ANRIL (Figure 2). Therefore, genotypes of
rs10757278 which are associated with an increased risk
of atherosclerotic diseases are also associated with a
decreased expression of genes CDKN2A, CDKN2B and
ARF, which encode products with known anti-prolifera-
tive functions, and, in addition, with a reduced expres-
sion of ANRIL itself [26]. Based on their findings, Liu
and co-workers suggested a potentially important role
for cell cycle inhibitors in atherosclerotic disease.
According to a regulation model derived from these
results, a polymorphic cis-regulatory element in close
linkage disequilibrium with rs10757278 influences the
expression of CDKN2A, CDKN2B and ARF which are
located approximately 120 kb from this SNP as well as
of ANRIL whose 3′-end is located in the direct neigh-
borhood of rs10757278 and which spans several other
risk-associated SNPs (Figure 2). Regulation of CDKN2A,
CDKN2B and ARF could be directly mediated by the
postulated polymorphic cis-regulatory element or, as
ANRIL overlaps with the upstream region of the
CDKN2A and ARF genes and the complete sequence of
CDKN2B, indirectly via ANRIL [26].
Jarinova and co-workers (2009) [25] performed an even
more detailed functional analysis of the 9p21.3 region in
an attempt to identify the molecular mechanisms respon-
sible for the increased risk for CHD. It turned out that
the risk haplotype can finally be reduced to one single
nucleotide variation, namely rs1333045, which seems to
be responsible for an increased expression of the short
splicing variants of the ANRIL regulatory RNA in homo-
zygous carriers of the risk allele as compared to carriers
Figure 1 Linkage disequilibrium (LD) map for the SNPs
genotyped in this study. The LD region 1 as described by
Schaefer et al. (2009) [17] is represented by the three SNPs
rs2891168, rs1333042, and rs1333048. The LD region 2 is
represented by SNP rs496892. The derived LD block structure is
shown for the Greifswald case-control cohort (n = 469) described in
this study. Numbers represent pair wise percent R2-values.
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of the non-risk allele, whereas the long ANRIL variant is
present in decreased amounts [25]. Jarinova and co-work-
ers were able to demonstrate a positive correlation
between the long splicing variant of ANRIL and the
amount of CDKN2A and CDKN2B specific mRNA. On
the other hand, the amount of CDKN2A and CDKN2B
specific mRNA is reduced in the homozygous carriers of
the risk allele who exhibited decreased amounts of the
long ANRIL variant and increased amounts of the short
splicing variants. The authors hypothesized that the SNP
(s), such as rs1333045, within the 9p21.3 locus may func-
tion as a molecular switch resulting in reciprocal changes
in expression levels of the short and long ANRIL tran-
scripts. According to this model, the risk allele causes
increased amounts of short ANRIL variants, which in
turn results in reduced expression of CDKN2A and
CDKN2B (and ARF). As CDKN2A, CDKN2B and ARF
encode proteins involved in negative cell cycle regulation
their down-regulation could be predicted to promote a
pro-proliferative phenotype. Indeed, genome-wide expres-
sion profiling performed by Jarinova and co-workers
(2009) [25] using whole-blood RNA demonstrated up-
regulation of gene sets modulating cellular proliferation
in homozygous carriers of the risk allele. Of particular
importance in the context of gAgP, gene sets relevant to
inflammation, including TNF/MAP kinase pathway sig-
naling in activated T-cells and interferon response genes
turned out to be differentially expressed. It is therefore
reasonable to suggest that the same molecular mechan-
isms involving the SNP rs1333045 that result in an
increased risk for CHD could also mediate the increased
risk for gAgP.
The SNPs rs1333045 and rs10757278, which were
extensively investigated [25,26], are located within the LD
region 1 between rs2891168 and rs1333048 that have been
genotyped in the current study (Figure 2). The chromoso-
mal order of the three SNPs in the LD region 1 which
were genotyped in our study (rs2891168, rs1333042, and
rs1333048) as well as rs1333045 and rs10757278 and the
corresponding R2 values as calculated using the HAPMAP
data are shown in Figure 3. The high values clearly con-
firm the LD structure of the region. Using the available
HAPMAP data for these five SNPs, a haplotype structure
which also considers the newly identified causative SNP
rs1333045 and rs10757278 was calculated (Table 5). Alto-
gether six haplotypes were obtained, and two (AATAA
and GGCGC) accounted for more than 92% of all haplo-
types detected at this locus according to the HAPMAP
data. Three of these (GGCGC, AACAA, and AACGC),
which together amounted to 53.5% of all haplotypes iden-
tified, exhibit the risk allele C of the putative causative
SNP rs1333045. Obviously, the risk allele is quite frequent
in the Caucasian population.
The number of gAgP cases in our case-control cohort
was similar to that analyzed by Schaefer and co-workers
(n = 130 versus n = 159), but the number of control
individuals was clearly smaller in our cohort (n = 339
versus n = 736). However, the information about the
periodontal condition of the control subjects described
as “free of periodontitis” in the cohort of Schaefer and
Figure 2 Transcriptional map of the human 9p21.3 locus associated with CHD and gAgP. The transcripts specifying CDKN2A, CDKN2B, ARF,
and ANRIL are shown as well as the four SNPs tested in this study (rs496892, rs2891168, rs1333042, rs1333048) and the two SNPs rs10757278
and 1333045 analyzed extensively in the studies of [26] and [25], respectively (illustration adopted from [26] and modified, by courtesy of
Norman E. Sharpless).
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co-workers was based solely on self-report of their oral
health status. In contrast, our control subjects were clas-
sified to be free of even low levels of periodontitis based
on an extensive dental examination. Therefore, the
more stringent ascertainment criteria for inclusion in
our control cohort should compensate for the smaller
number of individuals.
Most importantly, the combination of our genotyping
results with those from Schaefer and co-workers in a
meta-analysis for the SNPs rs2891168, rs1333042,
rs1333048, and rs496892 produced lower p-values as
compared to the results of both the individual studies in
the multiplicative model. It seems reasonable to propose
a multiplicative model for the whole locus covering both
LD regions, substantiating the earlier assumption of
Schaefer and co-workers that the underlying genetic
model might be “somewhere between the recessive and
the multiplicative one” [17].
The association data support the hypothesis which
predicts increased susceptibility for the development of
gAgP determined by the risk haplotype associated with
a pronounced general pro-proliferative and pro-inflam-
matory phenotype resulting from decreased expression
of the three cell-cycle inhibitor encoding genes
CDKN2A, ARF and CDKN2B.
The chromosomal region 9p21.3 probably does not
represent the sole susceptibility locus for the develop-
ment of gAgP. The predicted risk haplotypes, as calcu-
lated from the CEU HAPMAP data, amount to a total
frequency of 53.5%, which is surprisingly high in view of
the known low prevalence rate of gAgP. Therefore, in
addition to the influence of lifestyle factors, it can be
speculated that further genetic loci for gAgP exist.
These loci might exhibit stronger gene related effects in
their contribution to the increased risk for the develop-
ment of gAgP. A hypothesis-free Genome-wide Associa-
tion Study (GWAS) could represent the method of
choice to identify such predicted additional gAgP sus-
ceptibility genes. As a clinical implication of the verified
association between gAgP and the chromosomal region
9p21.3 that has been clearly associated with CHD in
earlier studies, it may be worth informing AgP patients
routinely of a possible increased risk of CHD.
Conclusions
In conclusion, using an independent case-control
cohort, we positively replicated the finding of an asso-
ciation between the chromosomal region 9p21.3 and
gAgP which was first described by Schaefer and co-
workers [17]. This result strengthens support for the
hypothesis that shared susceptibility genes within this
chromosomal locus might be involved in the pathogen-
esis of both CHD and gAgP.
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